BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29042802)

  • 1. Utilization of fetal fibronectin testing and pregnancy outcomes among women with symptoms of preterm labor.
    Blackwell SC; Sullivan EM; Petrilla AA; Shen X; Troeger KA; Byrne JD
    Clinicoecon Outcomes Res; 2017; 9():585-594. PubMed ID: 29042802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal fibronectin testing and pregnancy outcomes among Texas Medicaid patients at risk for preterm birth.
    Barner JC; Petrilla AA; Kang HA; Shen X; Alshehri AM; Sullivan EM; Troeger KA; Richards KM; Blackwell SC
    Am J Manag Care; 2017 Dec; 23(19 Suppl):S363-S370. PubMed ID: 29297659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management, Utilization, and Outcomes of Preterm Labor in an Integrated Health Care System.
    Getahun D; Sacks DA; Shi J; Xie F; Khadka N; Chiu VY; Mensah NA; Avila CC; Yeh M; Kawatkar AA; Ruma MS; Joyce D; Fassett MJ
    Am J Perinatol; 2024 May; ():. PubMed ID: 38714204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Preterm Labor Evaluation Visits and Extraction of Cervical Length Measures from Electronic Health Records Within a Large Integrated Health Care System: Algorithm Development and Validation.
    Xie F; Khadka N; Fassett MJ; Chiu VY; Avila CC; Shi J; Yeh M; Kawatkar A; Mensah NA; Sacks DA; Getahun D
    JMIR Med Inform; 2022 Sep; 10(9):e37896. PubMed ID: 36066930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of fetal fibronectin testing compared with digital cervical assessment of women with preterm contractions.
    Mateus J; Pereira L; Baxter J; Berghella V; Tolosa J
    Am J Perinatol; 2007 Jun; 24(6):381-5. PubMed ID: 17566945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal fibronectin testing for reducing the risk of preterm birth.
    Berghella V; Hayes E; Visintine J; Baxter JK
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD006843. PubMed ID: 18843732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative fetal fibronectin: who is still treating for threatened preterm labor and does it help?
    Peláez LM; Fox NS; Chasen ST
    J Perinat Med; 2008; 36(3):202-5. PubMed ID: 18576928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Economical impact of preterm delivery management based on fetal fibronectin results].
    García Alonso LA; Ayala Méndez JA; Jiménez Solís G; Aguilar Gutiérrez F; Díaz Cueto L
    Ginecol Obstet Mex; 2004 Aug; 72():385-93. PubMed ID: 15526554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Availability and use of fetal fibronectin testing and transvaginal ultrasound for preterm labor evaluation in the United States.
    Ruma MS; Banker WM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8586-8593. PubMed ID: 34648390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Fetal Fibronectin Test to Reduce Hospital Admissions with Diagnosis of Preterm Labor: An Economic Evaluation Study.
    Amro B; Alhalabi I; George A; Haroun H; Khamis AH; Sawalhi NA
    J Pers Med; 2023 May; 13(6):. PubMed ID: 37373883
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women.
    Bruijn M; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers H; Spaanderman M; Bloemenkamp K; Haak MC; Bolte AC; Vandenbussche F; Woiski MD; Bax CJ; Cornette J; Duvekot JJ; Nij Bijvanck B; van Eyck J; Franssen M; Sollie KM; van der Post J; Bossuyt P; Opmeer BC; Kok M; Mol B; van Baaren GJ
    BJOG; 2016 Nov; 123(12):1965-1971. PubMed ID: 26667313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study.
    Tanir HM; Sener T; Yildiz Z
    Clin Exp Obstet Gynecol; 2008; 35(1):61-4. PubMed ID: 18390084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal fibronectin in symptomatic twin gestations.
    Terrone DA; Rinehart BK; Kraeden U; Morrison JC
    Prim Care Update Ob Gyns; 1998 Jul; 5(4):179. PubMed ID: 10838333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
    Jun SY; Lee JY; Kim HM; Kim MJ; Cha HH; Seong WJ
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):241. PubMed ID: 31296172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
    Incerti M; Ghidini A; Korker V; Pezzullo JC
    Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.
    Ravi M; Beljorie M; El Masry K
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within 7 days.
    Hermans FJR; Bruijn MMC; Vis JY; Wilms FF; Oudijk MA; Porath MM; Scheepers HCJ; Bloemenkamp KWM; Bax CJ; Cornette JMJ; Nij Bijvanck BWA; Franssen MTM; Vandenbussche FPHA; Kok M; Grobman WA; Van Der Post JAM; Bossuyt PMM; Opmeer BC; Mol BWJ; Schuit E; Van Baaren GJ
    Acta Obstet Gynecol Scand; 2015 Jul; 94(7):715-721. PubMed ID: 25845495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of quantitative ultrasound tissue characterization of the cervix and rapid fetal fibronectin in predicting preterm delivery.
    Tekesin I; Wallwiener D; Schmidt S
    J Perinat Med; 2005; 33(5):383-91. PubMed ID: 16238532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.